Altered plasma apoE levels, potentially due to differential APOE expression between racial/ethnic groups, in conjunction with other factors including plasma lipids, may underlie the lower APOE ε4-induced risk of AD in B/AAs. Here, APOE is linked to Alzheimer disease.